Work

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

Year: 2022

Type: article

Abstract: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line recommendation for intermediate-stage HCC. In real-world clinical practice, TACE also plays an important role in early- and advanced-stage HCC. This review article by the experts from Chinese Liver Cancer Clinical Study Alliance (CHANCE) summarizes the available clinical evidence pertaining to the current application of TACE in patients with early-, intermediate-, and advanced-stage HCC. In addition, combination of TACE with other treatment modalities, especially immunotherapy, is reviewed.

Source: Journal of Clinical and Translational Hepatology

DOI: 10.14218/jcth.2022.00293

Authors: Bin-Yan Zhong, Zhi-Cheng Jin, Jian-Jian Chen, Hai-Dong Zhu, Xiao-Li Zhu

Institutions: First Affiliated Hospital of Soochow University, Zhongda Hospital Southeast University, Southeast University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4294724283

FWCI: 8.521

Cites: 87

Cited by: 73

Related to: 10